| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |